{"id":"https://openalex.org/W7215132434","doi":"https://doi.org/10.3389/fphar.2026.1960328","title":"Ensemble signal detection reveals target-specific temporal risk of hypokalemia after immune checkpoint inhibition: a translational pharmacology framework","display_name":"Ensemble signal detection reveals target-specific temporal risk of hypokalemia after immune checkpoint inhibition: a translational pharmacology framework","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7215132434","doi":"https://doi.org/10.3389/fphar.2026.1960328","pmid":"https://pubmed.ncbi.nlm.nih.gov/42889006","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13668552"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1960328","doi":"https://doi.org/10.3389/fphar.2026.1960328","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1960328","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1960328/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1960328/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5153733477","display_name":"Shengwang Chen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shengwang Chen","raw_affiliation_strings":["Department of Neurosurgery, The Third Hospital of Xiamen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, The Third Hospital of Xiamen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5154083260","display_name":"Ziyi Dai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91656880","display_name":"China Medical University","ror":"https://ror.org/032d4f246","country_code":"CN","type":"education","lineage":["https://openalex.org/I91656880"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ziyi Dai","raw_affiliation_strings":["The Second Clinical College of China Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Clinical College of China Medical University","institution_ids":["https://openalex.org/I91656880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076537976","display_name":"Zihan Guo","orcid":"https://orcid.org/0000-0003-4076-9386","observed_orcids":["https://orcid.org/0000-0003-4076-9386"]},"institutions":[{"id":"https://openalex.org/I191996457","display_name":"Dalian Medical University","ror":"https://ror.org/04c8eg608","country_code":"CN","type":"education","lineage":["https://openalex.org/I191996457"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zihan Guo","raw_affiliation_strings":["Dalian Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dalian Medical University","institution_ids":["https://openalex.org/I191996457"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108323490","display_name":"Ziyi Li","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91656880","display_name":"China Medical University","ror":"https://ror.org/032d4f246","country_code":"CN","type":"education","lineage":["https://openalex.org/I91656880"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ziyi Li","raw_affiliation_strings":["The Second Clinical College of China Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Second Clinical College of China Medical University","institution_ids":["https://openalex.org/I91656880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100737794","display_name":"Ruiqi Liu","orcid":"https://orcid.org/0000-0003-2228-4625","observed_orcids":["https://orcid.org/0000-0003-2228-4625"]},"institutions":[{"id":"https://openalex.org/I184693016","display_name":"China Medical University","ror":"https://ror.org/00v408z34","country_code":"TW","type":"education","lineage":["https://openalex.org/I184693016"]},{"id":"https://openalex.org/I91656880","display_name":"China Medical University","ror":"https://ror.org/032d4f246","country_code":"CN","type":"education","lineage":["https://openalex.org/I91656880"]}],"countries":["CN","TW"],"is_corresponding":false,"raw_author_name":"Ruiqi Liu","raw_affiliation_strings":["The First Clinical College of China Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The First Clinical College of China Medical University","institution_ids":["https://openalex.org/I184693016","https://openalex.org/I91656880"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5154030457","display_name":"Xuewen Jiang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Xuewen Jiang","raw_affiliation_strings":["Department of Neurosurgery, Xiamen Xinglin Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurosurgery, Xiamen Xinglin Hospital","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5154030457"],"corresponding_institution_ids":[],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.72460325,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"1960328","last_page":"1960328"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9868000149726868,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9729999899864197},{"id":"https://openalex.org/keywords/hypokalemia","display_name":"hypokalemia","score":0.996999979019165},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6809999942779541},{"id":"https://openalex.org/keywords/signal-detection","display_name":"signal detection","score":0.625},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.7799999713897705},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ctla-4-inhibitors","display_name":"CTLA-4 inhibitors","score":0.9769999980926514},{"id":"https://openalex.org/keywords/temporal-risk","display_name":"temporal risk","score":0.5009999871253967},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.621999979019165},{"id":"https://openalex.org/keywords/case-fatality","display_name":"case fatality","score":0.5820000171661377},{"id":"https://openalex.org/keywords/electrolyte-monitoring","display_name":"electrolyte monitoring","score":0.847000002861023},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.8349999785423279},{"id":"https://openalex.org/keywords/translational-pharmacology","display_name":"translational pharmacology","score":0.7269999980926514}],"concepts":[{"id":"https://openalex.org/C2778242168","wikidata":"https://www.wikidata.org/wiki/Q794086","display_name":"Hypokalemia","level":2,"score":0.6656000018119812},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6503000259399414},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5430999994277954},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5266000032424927},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.4620000123977661},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45989999175071716},{"id":"https://openalex.org/C187316915","wikidata":"https://www.wikidata.org/wiki/Q92307203","display_name":"Case fatality rate","level":3,"score":0.397599995136261},{"id":"https://openalex.org/C45942800","wikidata":"https://www.wikidata.org/wiki/Q245652","display_name":"Ensemble learning","level":2,"score":0.3926999866962433},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.3587999939918518},{"id":"https://openalex.org/C12174686","wikidata":"https://www.wikidata.org/wiki/Q1058438","display_name":"Risk assessment","level":2,"score":0.3547999858856201},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.3492000102996826},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34599998593330383},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.32760000228881836},{"id":"https://openalex.org/C2776190711","wikidata":"https://www.wikidata.org/wiki/Q7398663","display_name":"Safety pharmacology","level":3,"score":0.3264999985694885},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3197000026702881},{"id":"https://openalex.org/C107673813","wikidata":"https://www.wikidata.org/wiki/Q812534","display_name":"Bayesian probability","level":2,"score":0.3181999921798706},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.31520000100135803},{"id":"https://openalex.org/C49261128","wikidata":"https://www.wikidata.org/wiki/Q1132455","display_name":"Hazard","level":2,"score":0.31349998712539673},{"id":"https://openalex.org/C2779446555","wikidata":"https://www.wikidata.org/wiki/Q7663877","display_name":"Systems pharmacology","level":3,"score":0.2912999987602234},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.2897000014781952},{"id":"https://openalex.org/C12267149","wikidata":"https://www.wikidata.org/wiki/Q282453","display_name":"Support vector machine","level":2,"score":0.28690001368522644},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.27090001106262207},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2689000070095062},{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.26759999990463257},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.26649999618530273},{"id":"https://openalex.org/C191630685","wikidata":"https://www.wikidata.org/wiki/Q4027615","display_name":"Informatics","level":2,"score":0.26249998807907104},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.25870001316070557},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.2515999972820282},{"id":"https://openalex.org/C207201462","wikidata":"https://www.wikidata.org/wiki/Q182505","display_name":"Bayes' theorem","level":3,"score":0.2515999972820282}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3389/fphar.2026.1960328","doi":"https://doi.org/10.3389/fphar.2026.1960328","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1960328","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1960328/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmid:42889006","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42889006","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13668552","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13668552/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Pharmacol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:803716c0f97c48b2a279a2c2bee29851","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/803716c0f97c48b2a279a2c2bee29851","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1960328","doi":"https://doi.org/10.3389/fphar.2026.1960328","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1960328","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1960328/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7215132434.pdf","grobid_xml":"https://content.openalex.org/works/W7215132434.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1974283940","https://openalex.org/W1988100739","https://openalex.org/W2015487160","https://openalex.org/W2036195858","https://openalex.org/W2039594635","https://openalex.org/W2063686321","https://openalex.org/W2064716383","https://openalex.org/W2122495232","https://openalex.org/W2143772132","https://openalex.org/W2152874348","https://openalex.org/W2167186282","https://openalex.org/W2768429453","https://openalex.org/W2783137027","https://openalex.org/W2945590213","https://openalex.org/W2945976633","https://openalex.org/W2958089299","https://openalex.org/W3012372578","https://openalex.org/W3092800104","https://openalex.org/W4223430831","https://openalex.org/W4226351395","https://openalex.org/W4280590646","https://openalex.org/W4292478766","https://openalex.org/W4297172879","https://openalex.org/W4306692674","https://openalex.org/W4365446410","https://openalex.org/W4390344501","https://openalex.org/W4390738333","https://openalex.org/W4392292171","https://openalex.org/W4396583365","https://openalex.org/W4396696202","https://openalex.org/W4396937330","https://openalex.org/W4410481172","https://openalex.org/W4412763832","https://openalex.org/W4412805783","https://openalex.org/W4412844418","https://openalex.org/W4414273595","https://openalex.org/W4417182119","https://openalex.org/W7128006827"],"related_works":["https://openalex.org/W3200242337","https://openalex.org/W4396994185","https://openalex.org/W4402073382","https://openalex.org/W7159949286","https://openalex.org/W4414169193","https://openalex.org/W4319063759","https://openalex.org/W4306876457","https://openalex.org/W4411871958","https://openalex.org/W3021400531","https://openalex.org/W7133215871"],"abstract_inverted_index":{"Introduction:":[0],"Immune":[1],"checkpoint":[2],"inhibitors":[3,95,158],"(ICIs)":[4],"have":[5],"revolutionized":[6],"cancer":[7],"treatment,":[8],"but":[9],"traditional":[10],"pharmacovigilance":[11],"lacks":[12],"a":[13,125,136,192],"translational":[14,195],"computational":[15],"framework":[16,181],"capable":[17],"of":[18,24,140],"resolving":[19],"target-specific":[20,183],"nonlinear":[21,74],"temporal":[22,184],"risks":[23],"adverse":[25],"events":[26],"such":[27],"as":[28],"hypokalemia.":[29],"Methods:":[30],"We":[31],"integrated":[32],"3,243":[33],"ICI-related":[34],"hypokalemia":[35,133,162],"reports":[36],"from":[37,187],"the":[38,97,113],"FDA":[39],"Adverse":[40],"Event":[41],"Reporting":[42,61],"System":[43],"(FAERS)":[44],"and":[45,69,112,174,202],"VigiBase":[46],"(2014-2024).":[47],"An":[48,119],"ensemble":[49,180],"signal-detection":[50],"strategy":[51],"cross-validated":[52],"four":[53],"disproportionality":[54],"algorithms":[55],"(Reporting":[56],"Odds":[57],"Ratio":[58,62],"[ROR],":[59],"Proportional":[60],"[PRR],":[63],"Empirical":[64],"Bayesian":[65],"Geometric":[66],"Mean":[67],"[EBGM],":[68],"Information":[70],"Component":[71],"[IC]).":[72],"Flexible":[73],"survival":[75],"analysis":[76],"was":[77],"performed":[78],"using":[79],"restricted":[80],"cubic":[81],"spline":[82],"(RCS)":[83],"Cox":[84],"regression":[85],"to":[86,149],"model":[87],"time-to-event":[88],"dynamics.":[89],"Results:":[90],"Programmed":[91,155],"Death-Ligand":[92],"1":[93],"(PD-L1)":[94],"triggered":[96],"strongest":[98],"signal":[99],"(ROR":[100],"=":[101,167],"3.20,":[102],"95%":[103],"CI:":[104],"2.95-3.48),":[105],"with":[106,169],"ultra-early":[107],"onset":[108],"(median":[109],"23":[110],"days)":[111,132,145],"highest":[114],"case":[115],"fatality":[116],"rate":[117],"(23.7%).":[118],"asymmetric":[120],"biphasic":[121],"mortality":[122],"pattern":[123],"showed":[124],"nadir":[126],"at":[127,135],"60":[128],"days:":[129],"early-onset":[130],"(\u226430":[131],"peaked":[134],"hazard":[137],"ratio":[138,165],"(HR)":[139],"\u223c1.9,":[141],"whereas":[142],"late-onset":[143],"(>90":[144],"risk":[146,163],"gradually":[147],"rose":[148],"HR":[150],"\u223c1.8":[151],"within":[152],"350":[153],"days.":[154],"Death-1":[156],"(PD-1)":[157],"significantly":[159],"increased":[160],"severe":[161],"(odds":[164],"[OR]":[166],"28.32),":[168],"male":[170],"predominance":[171],"across":[172],"PD-1":[173],"CTLA-4":[175],"subgroups.":[176],"Discussion:":[177],"This":[178],"interpretable":[179],"reveals":[182],"toxicity":[185],"signatures":[186],"multi-source":[188],"real-world":[189],"data,":[190],"providing":[191],"computationally":[193],"grounded":[194],"pharmacology":[196],"foundation":[197],"for":[198],"precision":[199],"electrolyte":[200],"monitoring":[201],"mechanism-informed":[203],"safety":[204],"prediction.":[205]},"counts_by_year":[],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2026-10-02T00:00:00"}